Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · see citing works

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works

Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E

Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996 · see citing works

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · see citing works

Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · see citing works

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

Siebner, H. R., Riemenschneider, M. J., Willoch, F., Minoshima, S., Schwaiger, M., Kurz, A., Drzezga, A. E., & Lautenschlager, N. T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1194-1 · Cited by 603 · see citing works

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 2× · see citing works

Brain cytochrome oxidase in Alzheimer's disease

Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · see citing works

Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease

Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531 · see citing works

Electron transport chain defects in Alzheimer's disease brain

Parker, W. D., Parks, J. K., Filley, C. M., & Kleinschmidt-DeMasters, B. K. (1994) · Neurology · doi:10.1212/wnl.44.6.1090 · Cited by 495 · see citing works

Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease

Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467 · see citing works

Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500579102 · Cited by 401 · see citing works

Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses

Mandelkow�, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 397 · see citing works

Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative

Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · see citing works

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease

Bosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348 · see citing works

Copper-Dependent Inhibition of Human Cytochrome<i>c</i>Oxidase by a Dimeric Conformer of Amyloid-β_1-42

Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q.-X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-04.2005 · Cited by 327 · see citing works

Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease

Reddy, P. H., McWeeney, S. K., Park, B. S., Mańczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R. P., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 327 · see citing works

Posterior cingulate cortex in Alzheimer's disease

MINOSHIMA, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92871-1 · Cited by 316 · see citing works

Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines

Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P. M., Bennett, J. P., Miller, S. W., Davis, R. E., & Parker, W. D. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7333 · Cited by 296 · see citing works

Cytochrome c oxidase is decreased in Alzheimer’s disease platelets

Cardoso, S. M., Proença, M. T., Santos, S., Santana, I., & Oliveira, C. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00033-2 · Cited by 281 · see citing works

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

Drzezga, A. E., Grimmer, T., Riemenschneider, M., Lautenschlager, N. T., Siebner, H. R., Alexopoulus, P., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · PubMed · Cited by 277 · see citing works

Cybrids in Alzheimer's disease: a cellular model of the disease?

Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272 · see citing works

In vivo and in organello assessment of OXPHOS activities

Barrientos, A. (2002) · Methods · doi:10.1016/s1046-2023(02)00036-1 · Cited by 266 · see citing works

Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity

Cardoso, S. M., Santana, I. J., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 262 · see citing works

Cybrids in Alzheimer's disease: A cellular model of the disease?

Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260 · see citing works

Energy Inhibition Elevates β-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis

Velliquette, R. A., O'Connor, T., & Vassar, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-05.2005 · Cited by 254 · see citing works

Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease

Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249 · see citing works

Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration

Valla, J. E., Berndt, J. D., & Gonzalez-Lima, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04923.2001 · Cited by 237 · see citing works

Reduced platelet cytochrome c oxidase activity in Alzheimer's disease

Parker, W. D., Mahr, N., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., & Cullum, C. M. (1994) · Neurology · doi:10.1212/wnl.44.6.1086 · Cited by 199 · see citing works

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Pa, T., Krebs, C. T., Bennett, J. C., Parks, J. K., Swerdlow, R. H., et al. (2000) · PubMed · Cited by 176 · see citing works

Cytochrome C Oxidase in Alzheimer's Disease Brain: Purification and Characterization

Parker, W. D., & Parks, J. K. (1995) · Neurology · doi:10.1212/wnl.45.3.482 · Cited by 142 · see citing works

Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans

Krähenbühl, S., Talos, C., WIESMANN, U. N., & Hoppel, C. L. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90270-4 · Cited by 126 · see citing works

Clinical Deterioration in Probable Alzheimer's Disease Correlates with Progressive Metabolic Impairment of Association Areas

Mielke, R., Herholz, K., Grond, M., Kessler, J., & Heiß, W.-D. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106692 · Cited by 121 · see citing works

Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases

Chagnon, P., Bétard, C., Robitaille, Y., Cholette, A., & Gauvrea, D. (1995) · Neuroreport · doi:10.1097/00001756-199503270-00002 · Cited by 111 · see citing works

Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease

Sergeant, N., Wattez, A., Galvn-valencia, M., Ghestem, A., David, J., Lemoine, J., Sautire, P.-E., Dachary, J., Mazat, J., Michalski, J., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00747-9 · Cited by 103 · see citing works

Cybrids in Alzheimer's disease: A cellular model of the disease?

Schon, E. A., Shoubridge, E. A., & Moraes, C. T. (1998) · Neurology · doi:10.1212/wnl.51.1.326 · Cited by 101 · see citing works

Cyclosporin A Increases Resting Mitochondrial Membrane Potential in SY5Y Cells and Reverses the Depressed Mitochondrial Membrane Potential of Alzheimer's Disease Cybrids

Cassarino, D. S., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8866 · Cited by 98 · see citing works

Abnormalities in the Pattern of Platelet Amyloid Precursor Protein Forms in Patients With Mild Cognitive Impairment and Alzheimer Disease

Padovani, A., Borroni, B., Colciaghi, F., Pettenati, C., Cottini, E., Agosti, C., Lenzi, G. L., Caltagirone, C., Trabucchi, M., Cattabeni, F., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.71 · Cited by 98 · see citing works

What do mitochondrial diseases teach us about normal mitochondrial functions... that we already knew: threshold expression of mitochondrial defects

Mazat, J., Rossignol, R., Malgat, M., Rocher, C., Faustin, B., & Letellier, T. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00236-x · Cited by 85 · see citing works

Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture

Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.011 · Cited by 84 · see citing works

Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein

Luca, M. D., Colciaghi, F., Pastorino, L., Borroni, B., Padovani, A., & Cattabeni, F. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00559-8 · Cited by 82 · see citing works

β-Amyloid Neurotoxicity Is Exacerbated during Glycolysis Inhibition and Mitochondrial Impairment in the Rat Hippocampus in Vivo and in Isolated Nerve Terminals: Implications for Alzheimer's Disease

Arias, C., Montiel, T., Quiroz‐Baez, R., & Massieu, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7912 · Cited by 82 · see citing works

Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiography

Reiman, E. M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N. L., Berndt, J. D., & Games, D. (2000) · NeuroReport · doi:10.1097/00001756-200004070-00018 · Cited by 62 · see citing works

Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein

Dodart, J., Mathis, C., Bales, K. R., Paul, S. M., & Ungerer, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00847-2 · Cited by 60 · see citing works

Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing

Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., Pearson, J. V., Halperin, R. F., Dunckley, T. L., Papassotiropoulos, A., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.07.002 · Cited by 47 · see citing works

Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients

Gonzalez-Lima, F., Valla, J. E., & Matos-Collazo, S. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01464-3 · Cited by 43 · see citing works

Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice

Valla, J., Schneider, L. E., & Reiman, E. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.097 · Cited by 36 · see citing works

Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease

Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Benito‐León, J., Gasalla, T., Pareja, M. O., Vela, L., Bermejo, F., Martín, M. A., Campos, Y., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.636 · Cited by 32 · see citing works

Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the swedish mutation

Strazielle, C., Sturchler, C., Staufenbiel, M., & Lalonde, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00037-x · Cited by 30 · see citing works

Untitled work

Khan (2000) · doi:10.1002/1531-8249(200008)48:2

The Alzheimer’s Disease Mitochondrial Cascade Hypothesis

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562 · see citing works

Estrogen: A master regulator of bioenergetic systems in the brain and body

Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies

Mosconi, L. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0026-y · Cited by 328 · see citing works

Insulin in Central Nervous System: More than Just a Peripheral Hormone

Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 324 · see citing works

Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer’s Disease

Hroudová, J., Singh, N., & Fišar, Z. (2014) · BioMed Research International · doi:10.1155/2014/175062 · Cited by 319 · see citing works

Brain aging, Alzheimer's disease, and mitochondria

Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.012 · Cited by 306 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Mitochondria: A therapeutic target in neurodegeneration

Moreira, P. I., Zhu, X., Wang, X., Lee, H., Nunomura, A., Petersen, R. B., Perry, G. L., & Smith, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 286 · see citing works

Diabetes and Alzheimer’s disease crosstalk

Baglietto‐Vargas, D., Shi, J. J., Yaeger, D. M., Ager, R. R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 254 · see citing works

Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease

Zhu, X., Perry, G., Smith, M. A., & Wang, X. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129005 · Cited by 242 · see citing works

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Holper, L., Ben‐Shachar, D., & Mann, J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0090-0 · Cited by 234 · see citing works

Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects

Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221 · see citing works

Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?

Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212 · see citing works

Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease

Guo, L., Tian, J., & Du, H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160702 · Cited by 211 · see citing works

The Alzheimer's disease mitochondrial cascade hypothesis: an update

Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206 · see citing works

Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease

Swerdlow, R. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4149 · Cited by 203 · see citing works

Mitochondria in Neurodegeneration

Lezi, E., & Swerdlow, R. H. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_12 · Cited by 204 · see citing works

Molecular links between Alzheimer’s disease and diabetes mellitus

Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201 · see citing works

Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease

Rothman, S. M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8107-9 · Cited by 197 · see citing works

Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation

Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195 · see citing works

Mitochondrial genes are altered in blood early in Alzheimer's disease

Lunnon, K., Keohane, A., Pidsley, R., Newhouse, S., Riddoch-Contreras, J., Thubron, E. B., Devall, M., Soininen, H., Kłoszewska, I., Mecocci, P., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.029 · Cited by 190 · see citing works

Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell

Gan, X., Huang, S., Wu, L., Wang, Y., Hu, G., Li, G., Zhang, H., Yu, H., Swerdlow, R. H., Chen, J. X., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.009 · Cited by 180 · see citing works

Mitochondrial DNA Oxidative Damage and Repair in Aging and Alzheimer's Disease

Santos, R. X., Correia, S. C., Zhu, X., Smith, M. A., Moreira, P. I., Castellani, R. J., Nunomura, A., & Perry, G. L. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5039 · Cited by 176 · see citing works

Multiple Defects in Energy Metabolism in Alzheimers Disease

Ferreira, I. L., Resende, R., Ferreiro, E. B., Rego, A. C., & Pereira, C. (2010) · Current Drug Targets · doi:10.2174/1389450111007011193 · Cited by 181 · see citing works

Role of mitochondrial homeostasis and dynamics in Alzheimer's disease

Selfridge, J. E., E, L., Lu, J., & Swerdlow, R. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.057 · Cited by 175 · see citing works

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies

Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157 · see citing works

Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene

Valla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150 · see citing works

Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood

Lunnon, K., Ibrahim, Z. M., Proitsi, P., Lourdusamy, A., Newhouse, S., Sattlecker, M., Furney, S. J., Saleem, M., Soininen, H. S., Kłoszewska, I., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111592 · Cited by 143 · see citing works

The role of mitochondria in neurodegenerative diseases

Filosto, M., Scarpelli, M., Cotelli, M. S., Vielmi, V., Todeschini, A., Gregorelli, V., Tonin, P., Tomelleri, G., & Padovani, A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6104-z · Cited by 140 · see citing works

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?

Bell, S., Barnes, K., Marco, M. D., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Venneri, A., & Mortiboys, H. (2021) · Biomedicines · doi:10.3390/biomedicines9010063 · Cited by 136 · see citing works

Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines

Silva, D. F., Selfridge, J. E., Lu, J., E, L., Roy, N., Hutfles, L., Burns, J. M., Michaelis, E. K., Yan, S., Cardoso, S. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt247 · Cited by 133 · see citing works

Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes

Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 127 · see citing works

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

Han, R., Liang, J., & Zhou, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115887 · Cited by 125 · see citing works

Mitochondrial dysfunction and Alzheimer's disease

Maruszak, A., & Żekanowski, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.004 · Cited by 123 · see citing works

Shift in brain metabolism in late onset Alzheimer’s disease: Implications for biomarkers and therapeutic interventions

Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 124 · see citing works

Re-emphasizing early Alzheimer’s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy

Kobro-Flatmoen, A., Lagartos-Donate, M. J., Aman, Y., Edison, P., Witter, M. P., & Fang, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101307 · Cited by 112 · see citing works

Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆

Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 119 · see citing works

Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein

Pavlov, P. F., Wiehager, B., Sakai, J., Frykman, S., Behbahani, H., Winblad, B. G., & Ankarcrona, M. (2010) · The FASEB Journal · doi:10.1096/fj.10-157230 · Cited by 113 · see citing works

The Neurodegenerative Mitochondriopathies

Swerdlow, R. H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1095 · Cited by 112 · see citing works

Mitochondrial Metabolism Power SIRT2-Dependent Deficient Traffic Causing Alzheimer’s-Disease Related Pathology

Silva, D. F., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9951-x · Cited by 110 · see citing works

Mitochondria, Cybrids, Aging, and Alzheimer's Disease

Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106 · see citing works

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110 · see citing works

Mitochondrial respiration as a target for neuroprotection and cognitive enhancement

Gonzalez-Lima, F., Barksdale, B. R., & Rojas, J. C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.010 · Cited by 105 · see citing works

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease

Mosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97 · see citing works

Estrogen Regulation of Mitochondrial Bioenergetics

Yao, J., & Brinton, R. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00010-6 · Cited by 97 · see citing works

Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease

Park, S.-S., Park, H.-S., Kim, C., Kang, H., Kim, D., Baek, S., & Kim, T.-W. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00631-4 · Cited by 89 · see citing works

Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?

Veitinger, M., Varga, B., Guterres, S. B., & Zellner, M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-65 · Cited by 87 · see citing works

Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks

Correia, S. C., Perry, G. L., & Moreira, P. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.010 · Cited by 88 · see citing works

Exercise as a Positive Modulator of Brain Function

Alkadhi, K. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0516-4 · Cited by 90 · see citing works

Mitochondrial Abnormalities in Alzheimer’s Disease

Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86 · see citing works

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes

Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85 · see citing works

The protective role of plant biophenols in mechanisms of Alzheimer's disease

Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 82 · see citing works

Mitochondrial medicine for neurodegenerative diseases

Du, H., & Yan, S. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.004 · Cited by 81 · see citing works

APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease

Wolf, A. B., Caselli, R. J., Reiman, E. M., & Valla, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.011 · Cited by 79 · see citing works

Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer’s Disease and Mild Cognitive Impairment Patients

Delbarba, A., Abate, G., Prandelli, C., Marziano, M., Buizza, L., Varas, N. A., Novelli, A., Cuetos, F., Martínez, C., Lanni, C., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5923938 · Cited by 80 · see citing works

Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?

Balietti, M., Giuli, C., & Conti, F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0866-y · Cited by 76 · see citing works

Flexible Nets of Malleable Guardians: Intrinsically Disordered Chaperones in Neurodegenerative Diseases

Uversky, V. N. (2010) · Chemical Reviews · doi:10.1021/cr100186d · Cited by 75 · see citing works

Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia

Carvalho, C., Correia, S. C., Santos, R. X., Cardoso, S., Moreira, P. I., Clark, T. A., Zhu, X., Smith, M. A., & Perry, G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9247-1 · Cited by 72 · see citing works

Clinical Features and Pathogenesis of Alzheimer’s Disease: Involvement of Mitochondria and Mitochondrial DNA

Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., & Siciliano, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_4 · Cited by 69 · see citing works

Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine

Cardoso, S., Carvalho, C., Correia, S. C., Seiça, R. M. F., & Moreira, P. I. (2016) · Brain Pathology · doi:10.1111/bpa.12402 · Cited by 67 · see citing works

The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment

Iyalomhe, O., Swierczek, S. I., Enwerem, N. Y., Chen, Y., Adedeji, M. O., Allard, J. S., Ntekim, O. E., Johnson, S. M., Hughes, K., Kurian, P., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0440-6 · Cited by 64 · see citing works

Blood‐Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism

Tyrrell, D. J., Bharadwaj, M. S., Jorgensen, M. J., Register, T. C., Shively, C. A., Andrews, R. N., Neth, B. J., Keene, C. D., Mintz, A., Craft, S., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7317251 · Cited by 66 · see citing works

Reassessment of Pioglitazone for Alzheimer’s Disease

Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 67 · see citing works

Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases

Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_16 · Cited by 64 · see citing works

Redefining oxidative stress in Alzheimer's disease: Targeting platelet reactive oxygen species for novel therapeutic options

Beura, S. K., Dhapola, R., Panigrahi, A. R., Yadav, P., HariKrishnaReddy, D., & Singh, S. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120855 · Cited by 64 · see citing works

Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder

Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 63 · see citing works

Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction

Gan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Swerdlow, R. H., Chen, J. X., & Yan, S. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.021 · Cited by 62 · see citing works

New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease

Samanta, S., Akhter, F., Roy, A., Chen, D., Turner, B., Wang, Y., Clemente, N., Wang, C., Swerdlow, R. H., Battaile, K. P., et al. (2023) · Brain · doi:10.1093/brain/awad432 · Cited by 62 · see citing works

Mutations that affect mitochondrial functions and their association with neurodegenerative diseases

Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 61 · see citing works

Mitochondrial preconditioning: a potential neuroprotective strategy

Correia, S. C. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00138 · Cited by 58 · see citing works

Mitochondrial links between brain aging and Alzheimer’s disease

Wilkins, H., & Swerdlow, R. H. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00261-2 · Cited by 53 · see citing works

Genetic association of the cytochrome c oxidase-related genes with Alzheimer’s disease in Han Chinese

Bi, R., Zhang, W., Zhang, D., Xu, M., Fan, Y., Hu, Q.-X., Jiang, H., Tan, L., Li, T., Fang, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0144-3 · Cited by 53 · see citing works

Maternal Cognitive Impairment Associated with Gestational Diabetes Mellitus—A Review of Potential Contributing Mechanisms

John, C. M., Yusof, N. I. S. M., Aziz, S. H. A., & Fauzi, F. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123894 · Cited by 52 · see citing works

Triad of Risk for Late Onset Alzheimer’s: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex

Wang, Y., & Brinton, R. D. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00232 · Cited by 52 · see citing works

A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer’s Disease Subjects: Results of a Single-Arm, Pilot Trial

Wilkins, H., Mahnken, J. D., Welch, P., Bothwell, R. J., Koppel, S. J., Jackson, R. L., Burns, J. M., & Swerdlow, R. H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170077 · Cited by 51 · see citing works

Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity

Choi, J., Chandrasekaran, K., Demarest, T. G., Kristián, T., Xu, S., Vijaykumar, K., Dsouza, K. G., Qi, N., Yarowsky, P., Gallipoli, R., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.86 · Cited by 50 · see citing works

Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer’s disease Mouse Brain

Du, F., Zhang, Z., Li, H., Yu, Q., Douglas, J. T., Bratasz, A., Kuppusamy, P., & Yan, S. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150917 · Cited by 48 · see citing works

Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease

Duarte, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.044 · Cited by 48 · see citing works

Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's

Mosconi, L., Glodzik, L., Mistur, R., McHugh, P., Rich, K. E., Javier, E., Williams, S., Pirraglia, E., De Santi, S., Mehta, P. D., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.011 · Cited by 46 · see citing works

Assessment of Platelet Respiration as Emerging Biomarker of Disease

Petruş, A., Lighezan, D. L., Dănilă, M. D., Duicu, O., Sturza, A., Muntean, D. M., & Ioniță, I. (2019) · Physiological Research · doi:10.33549/physiolres.934032 · Cited by 45 · see citing works

Ginsenoside Rg1 Attenuates Oligomeric Aβ1-42-Induced Mitochondrial Dysfunction

Huang, T., Fang, F., Chen, L., Zhu, Y., Zhang, J., Chen, X., & Yan, S. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107636 · Cited by 41 · see citing works

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months

Thai, C., Lim, Y. Y., Villemagne, V. L., Laws, S. M., Ames, D. J., Ellis, K. A., Rainey‐Smith, S. R., Martins, R. N., Masters, C. L., Rowe, C. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139082 · Cited by 39 · see citing works

O-GlcNAcylation and neuronal energy status: Implications for Alzheimer’s disease

Pinho, T. S., Verde, D. V., Correia, S. C., Cardoso, S., & Moreira, P. I. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.003 · Cited by 38 · see citing works

Biomarkers: Our Path Towards a Cure for Alzheimer Disease

Tarawneh, R. M. (2020) · Biomarker Insights · doi:10.1177/1177271920976367 · Cited by 37 · see citing works

Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease

Babylon, L., Grewal, R., Stahr, P.-L., Eckert, R. W., Keck, C. M., & Eckert, G. P. (2021) · Antioxidants · doi:10.3390/antiox10071003 · Cited by 37 · see citing works

Inhibition of mitochondrial cytochrome c oxidase potentiates Aβ-induced ER stress and cell death in cortical neurons

Costa, R. O., Ferreiro, E. B., Oliveira, C. R., & Pereira, C. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.005 · Cited by 34 · see citing works

Polymorphic variation in cytochrome oxidase subunit genes

Lu, J., Wang, K., Rodova, M., Esteves, R., Berry, D., E, L., Crafter, A., Barrett, M., Cardoso, S. M., Onyango, I., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100123 · Cited by 33 · see citing works

The Role of Gut Microbiota-Derived Trimethylamine N-Oxide in the Pathogenesis and Treatment of Mild Cognitive Impairment

Xie, H., Jiang, J., Cao, S., Xu, X., Zhou, J., Zhang, R., Huang, B., Lu, P., Peng, L., & Liu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031373 · Cited by 33 · see citing works

Alzheimer disease as a vascular disorder: Where do mitochondria fit?

Correia, S. C., Santos, R. X., Cardoso, S., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.006 · Cited by 32 · see citing works

Analysis of calcium homeostasis in fresh lymphocytes from patients with sporadic Alzheimer's disease or mild cognitive impairment

Jaworska, A. M., Dzbek, J., Styczyńska, M., & Kuźnicki, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.012 · Cited by 31 · see citing works

Platelet mitochondrial dysfunction and mitochondria-targeted quinone-and hydroquinone-derivatives: Review on new strategy of antiplatelet activity

Fuentes, M., Araya‐Maturana, R., Palomo, I. F., & Eduardo Fuentes, Q. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.035 · Cited by 30 · see citing works

Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis

Iñarrea, P., Alarcia, R., Álava, M. A., Capablo, J. L., Casanova, A., Íñiguez, C., Iturralde, M., Larrodé, P., Martín, J., Mostacero, E., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8481-z · Cited by 29 · see citing works

Proteomic analysis of the dorsal and ventral hippocampus of rats maintained on a high fat and refined sugar diet

Francis, H., Mirzaei, M., Pardey, M. C., Haynes, P. A., & Cornish, J. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201300124 · Cited by 28 · see citing works

Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons

Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2018) · Journal of neural transmission · doi:10.1007/s00702-017-1832-6 · Cited by 28 · see citing works

Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease

Feldhaus, P., Fraga, D. B., Ghedim, F. V., De Luca, R. D., Bruna, T. D., Heluany, M., Matos, M. P., Ferreira, G. K., Jeremias, I. C., Heluany, C., et al. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9253-y · Cited by 27 · see citing works

Alterations in Mitochondrial Dynamic-related Genes in the Peripheral Blood of Alzheimer’s Disease Patients

Pakpian, N., Phopin, K., Kitidee, K., Govitrapong, P., & Wongchitrat, P. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201006162538 · Cited by 27 · see citing works

Bibliometric Analysis Study on the Mechanisms of Brain Energy Metabolism Disorders in Alzheimer's Disease From 2000 to 2020

Du, Y.-H., Yang, R., Wang, Q., Wang, L., Liang, L., Zhu, L., Sun, Y., & Cai, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.670220 · Cited by 27 · see citing works

Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle

Morris, J. K., McCoin, C. S., Fuller, K. N. Z., John, C. S., Wilkins, H., Green, Z. D., Wang, X., Sharma, P., Burns, J. M., Vidoni, E. D., et al. (2021) · Function · doi:10.1093/function/zqab045 · Cited by 25 · see citing works

Low-density platelet populations demonstrate lowin vivoactivity in sporadic Alzheimer disease

Järemo, P., Milovanovic, M., Buller, C., Nilsson, S., & Winblad, B. G. (2011) · Platelets · doi:10.3109/09537104.2011.593654 · Cited by 26 · see citing works

Identification of a novel platelet complex III deficit in Alzheimer’s disease and mild cognitive impairment

Valla, J., Schneider, L. E., & Niedzielko, T. L. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.08.055

Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease

Fišar, Z., Hroudová, J., Hansíková, H., Křížová, J., Lelková, P., Wenchich, L., Jirák, R., Zvěřová, M., Zeman, J., Pavel Martasek, E., et al. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314150856 · Cited by 82 · see citing works

Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer’s Disease and Mild Cognitive Impairment Patients

Delbarba, A., Abate, G., Prandelli, C., Marziano, M., Buizza, L., Varas, N. A., Novelli, A., Cuetos, F., Martínez, C., Lanni, C., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5923938 · Cited by 80 · see citing works

Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder

Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 63 · see citing works

Mitochondrial dysfunction manifests in the early stages of Alzheimer disease

Wood, H. B. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0353-3 · Cited by 14 · see citing works